Clinical Trial Update: Efficacy and Safety of Dioxidin Versus Miramistin in Superficial Pyoderma [Phase 3]

View source ↗

Summary

Phase 3 clinical trial comparing Dioxidin to Miramistin for superficial pyoderma has completed; efficacy and safety data were collected.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pyoderma

Drugs mentioned

• Dioxidin (Dioxidin)
• Miramistin (Miramistin)

Snippet

Sponsor: Valenta Pharm JSC | Conditions: Pyoderma | Phase 3 | Status: COMPLETED